In vitro screening for seizure liability using microelectrode array technology

Bradley JA, Luithardt HH,  Metea MR, Strock CJ.

Toxicol Sci, 2018


Discover how Maestro MEA technology makes it possible to identify seizurogenic drug effects at early stages of the development process, ensuring the development of safe candidate compounds.

Keywords: Seizure liability, neurotoxicity, safety, GABA antagonist, glycine receptor antagonist